Tier 2 Validation definition

Tier 2 Validation means [ * ].
Sample 1

Examples of Tier 2 Validation in a sentence

  • Tier 2 Validation Checks: Quarterly, automated production-level checks for reasonableness of submitted data, including month-over-month trend analyses to validate consistency in data volume and quality.

  • Tier 2 Validation Checks will be reviewed and approved by the ISW annually.

  • NC DHHS HCBS validation will be completed December 31, 2022.Tier 2 DHHS ValidationThe DHHS HCBS Internal Team completed Tier 2 Validation (also referred to as look behind) reviews; from a sample of LME/MCO validated provider self-assessments.

  • They submitted an updated Auxiliary Aids plan, and this PIP is closed as 6/30/21.• The Recovery Research Network – There were 2 findings from the Tier 2 Validation Report that require a Corrective Action and a Performance Improvement Plan for deficiencies in the submission of discharge records to the Carisk portal and a lack of established policies and procedures related to the timely, consistent, and accurate entry of such data.

  • There was no Performance Improvement issued, however there is one corrective action that requires the provider to complete their missing discharges.• Counseling and Recovery Center: During the 2nd Quarter, a Tier 2 Validation was completed.

  • The number of collaborative projects currently underway proves that the VCS is making this cultural shift, albeit led by - or targeted at - larger or national charities rather than smaller, local organisations, as demonstrated later in this Report.

  • These caps just slide in and are held in place by the Rocker Cover.

  • They must still submit an updated Auxiliary Aids plan with an agreed date of 2/17/2021. The Recovery Research Network – There were 2 findings from the Tier 2 Validation Report that require a Corrective Action and a Performance Improvement Plan for deficiencies in the submission of discharge records to the Carisk portal and a lack of established policies and procedures related to the timely, consistent, and accurate entry of such data.

Related to Tier 2 Validation

  • Validation as used in WAC 222-20-016, means the department's agreement that a small forest landowner has correctly identified and classified resources, and satisfactorily completed a roads assessment for the geographic area described in Step 1 of a long-term application.

  • Tier 3 Wire Centers are those Embarq Wire Centers that are not Tier 1 or Tier 2 Wire Centers.

  • Outpatient treatment means mental health or substance abuse treatment services rendered to a

  • Inpatient treatment means twenty-four-hour-per-day mental

  • In Patient Care means treatment for which the insured person has to stay in a hospital for more than 24 hours for a covered event.

  • Phase 3 Clinical Trial means a pivotal clinical trial in humans performed to gain evidence with statistical significance of the efficacy of a product in a target population, and to obtain expanded evidence of safety for such product that is needed to evaluate the overall benefit-risk relationship of such product, to form the basis for approval of an NDA and to provide an adequate basis for physician labeling, as described in 21 C.F.R. § 312.21(c) or the corresponding regulation in jurisdictions other than the United States.

  • Phase II Clinical Trial means a controlled human clinical study that would satisfy the requirements of 21 CFR 312.21(b), conducted to study the effectiveness and establish the dose range of a Product for a particular Indication in patients with the disease or condition under study, including a Phase IIA Clinical Study or Phase IIB Clinical Study.

  • preferential tariff treatment means the rate of customs duties applicable to an originating good in accordance with paragraph 1 of Article 2.8;

  • Phase III Clinical Trial means a human clinical trial, the principal purpose of which is to demonstrate clinically and statistically the efficacy and safety of a Licensed Product for one or more indications in order to obtain Marketing Approval of such Licensed Product for such indication(s), as further defined in 21 C.F.R. §312.21 or a similar clinical study in a country other than the United States.

  • Subject of a Clinical Trial means the health care service, item, or drug that is being evaluated in the Approved Clinical Trial and that is not a Routine Patient Cost.

  • Phase 2 Clinical Trial means a human clinical trial of a product in any country that would satisfy the requirements of 21 C.F.R. 312.21(b) and is intended to explore a variety of doses, dose response, and duration of effect, and to generate initial evidence of clinical safety and activity in a target patient population, or a similar clinical study prescribed by the relevant Regulatory Authorities in a country other than the United States.

  • Clinical Trial means a Phase I Clinical Trial, Phase II Clinical Trial or Phase III Clinical Trial, or any post-approval human clinical trial, as applicable.

  • Assisted outpatient treatment or "AOT" means the categories of outpatient services ordered by the court under section 468 or 469a. Assisted outpatient treatment may include a case management plan and case management services to provide care coordination under the supervision of a psychiatrist and developed in accordance with person-centered planning under section 712. Assisted outpatient treatment may also include 1 or more of the following categories of services: medication; periodic blood tests or urinalysis to determine compliance with prescribed medications; individual or group therapy; day or partial day programming activities; vocational, educational, or self-help training or activities; assertive community treatment team services; alcohol or substance use disorder treatment and counseling and periodic tests for the presence of alcohol or illegal drugs for an individual with a history of alcohol abuse or substance use disorder; supervision of living arrangements; and any other services within a local or unified services plan developed under this act that are prescribed to treat the individual's mental illness and to assist the individual in living and functioning in the community or to attempt to prevent a relapse or deterioration that may reasonably be predicted to result in suicide, the need for hospitalization, or serious violent behavior. The medical review and direction included in an assisted outpatient treatment plan shall be provided under the supervision of a psychiatrist.

  • Tier 1 Support means the Technical Support provided by the Tier 1 Help Desk.

  • Tier 2 means the portion of the design- related information contained in the generic DCD that is approved but not certified by this appendix (Tier 2 information). Compli- ance with Tier 2 is required, but generic changes to and plant-specific departures from Tier 2 are governed by Section VIII of this appendix. Compliance with Tier 2 pro- vides a sufficient, but not the only accept- able, method for complying with Tier 1. Compliance methods differing from Tier 2 must satisfy the change process in Section VIII of this appendix. Regardless of these dif- ferences, an applicant or licensee must meet the requirement in Section III.B of this ap- pendix to reference Tier 2 when referencing Tier 1. Tier 2 information includes:

  • Tier 2 Support means the Esri Technical Support provided to the Tier 1 Help Desk when a Case cannot be resolved through Tier 1 Support.

  • Phase 1 Clinical Trial means a Clinical Trial of a Product on sufficient numbers of normal volunteers and/or patients that is designed to establish that such Product is safe for its intended use and to support its continued testing in Phase 2 Clinical Trials. For purposes of this Agreement, ‘initiation’ of a Phase 1 Clinical Trial for a Product means the first dosing of such Product in a human subject in a Phase 1 Clinical Trial.

  • Tier 1 Help Desk means Customer's point of contact(s) to provide all Tier 1 Support within Customer's organization(s).

  • Phase III Clinical Trials means a Clinical Trial for the Product on sufficient numbers of patients to generate safety and efficacy data to support Regulatory Approval in the proposed therapeutic indication, conducted in accordance with current good clinical practices and in accordance with a protocol that has been reviewed by the FDA and reflects any comments or concerns raised by the same.

  • Phase 4 Clinical Trial means a Clinical Trial of a Product conducted after Regulatory Approval of such Product has been obtained from an appropriate Regulatory Authority, which trial is (a) conducted voluntarily by a Party to enhance marketing or scientific knowledge of the Product, or (b) conducted due to a request or requirement of a Regulatory Authority.

  • Clinical evaluation means a systematic and planned process to continuously generate, collect, analyse and assess the clinical data pertaining to a device in order to verify the safety and performance, including clinical benefits, of the device when used as intended by the manufacturer;

  • clinical evidence means clinical data and clinical evaluation results pertaining to a device of a sufficient amount and quality to allow a qualified assessment of whether the device is safe and achieves the intended clinical benefit(s), when used as intended by the manufacturer;

  • Phase I Clinical Trial means a clinical trial conducted in healthy humans or patients, which clinical trial is designed to establish the safety, drug-drug interactions and/or pharmacokinetics of an investigational drug given its intended use, and to support continued testing of such drug in Phase II Clinical Trials.

  • Phase IV Clinical Trial means a Clinical Trial conducted after a Product achieves Regulatory Approval, carried out for purposes of conducting safety surveillance and ongoing technical support of the Product.

  • CEC Certification and Verification means that the CEC has certified (or, with respect to periods before the Project has commenced commercial operation (as such term is defined by and according to the CEC), that the CEC has pre-certified) that the Project is an ERR for purposes of the California Renewables Portfolio Standard and that all Energy produced by the Project qualifies as generation from an ERR for purposes of the Project.

  • Phase II Clinical Study means a human clinical study of a product initiated to determine the safety and efficacy in the target patient population, as described 21 C.F.R. 312.21(b).